FDA online resources provide a comprehensive list of pharmacogenomics biomarkers for FDA-approved drugs and medications for cancers, cardiovascular, lipid metabolism, diabetes, gastrointestinal, infectious diseases, neurological, pain, psychiatry and addiction, rheumatology, gynecology, and urological conditions. At the molecular level, certain genes are responsible for how the body processes different medications, and pharmacogenomics combines our understanding of medication metabolism with genetics. Genetic variations may determine the effectiveness or potential side effects to a specific medication. Let us help your physician and you to know your genetics to personalize your medication. The sample reports for comprehensive pharmacogenomics and for pain medication pharmacogenomics genetic testing illustrate the benefits of pharmacogenomics (PGx) genetic testing:
Once the PGx test is completed, we want you to have the information you need to create a personalized approach to prescription medicine.